Cindy Bayley, PhD ’90, MBA ’97
Affiliate, ARCH Venture Partners
Cindy is an affiliate at ARCH Venture Partners. She focuses on life science businesses and is a cofounder of several ARCH portfolio companies, including deCODE genetics, an Icelandic diagnostics company; Adolor, a pharmaceutical firm developing novel analgesics; and Elixir Pharmaceuticals, an anti-aging and metabolic disease company. Cindy has worked with ARCH since 1992 and has been instrumental in sourcing companies like Alnylam Pharmaceuticals and Agios Pharmaceuticals. She has also participated in the planning and diligence for many other companies in the portfolio. Early in her career, she was a general field engineer with Schlumberger Offshore Services. She holds a BS in physics from the University of Rochester and an MBA and PhD in virology from the University of Chicago.